TreeWAS – Variant ID: rs11989843

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T39.1 4-Aminophenol derivatives	0.040	0.960	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.040	0.960	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.039	0.961	0.000
T39.0 Salicylates	0.036	0.964	0.000
Z34.8 Supervision of other normal pregnancy	0.030	0.970	0.000
T39.4 Antirheumatics, not elsewhere classified	0.029	0.971	0.000
T39.2 Pyrazolone derivatives	0.029	0.971	0.000
N13 Obstructive and reflux uropathy	0.027	0.973	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.026	0.974	0.000
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.026	0.974	0.000
N13.4 Hydroureter	0.026	0.974	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.025	0.974	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.025	0.975	0.000
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.022	0.977	0.000
N13.7 Vesicoureteral-reflux-associated uropathy	0.022	0.978	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.022	0.978	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.021	0.979	0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.021	0.979	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.020	0.980	0.000
T43.2 Other and unspecified antidepressants	0.020	0.980	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.020	0.980	0.000
N13.8 Other obstructive and reflux uropathy	0.019	0.981	0.000
N13.9 Obstructive and reflux uropathy, unspecified	0.019	0.981	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.019	0.981	0.000
N13.6 Pyonephrosis	0.019	0.981	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.018	0.982	0.000
T40.4 Other synthetic narcotics	0.018	0.982	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.018	0.982	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.017	0.983	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.017	0.983	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.016	0.984	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.016	0.984	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.016	0.984	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.016	0.984	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.015	0.984	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.015	0.985	0.000
T36 Poisoning by systemic antibiotics	0.015	0.985	0.000
C82.2 Large cell, follicular	0.015	0.985	0.000
T38.9 Other and unspecified hormone antagonists	0.015	0.985	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.015	0.985	0.000
T38.7 Androgens and anabolic congeners	0.015	0.985	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.015	0.985	0.000
T38.5 Other oestrogens and progestogens	0.015	0.985	0.000
T38.4 Oral contraceptives	0.015	0.985	0.000
T38.2 Antithyroid drugs	0.015	0.985	0.000
T38.0 Glucocorticoids and synthetic analogues	0.015	0.985	0.000
T38.1 Thyroid hormones and substitutes	0.015	0.985	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.015	0.985	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.015	0.985	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.015	0.985	0.000
T43.9 Psychotropic drug, unspecified	0.014	0.986	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.014	0.986	0.000
C82.3 Follicular lymphoma grade IIIa	0.014	0.986	0.000
T43.6 Psychostimulants with abuse potential	0.014	0.986	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.014	0.986	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.014	0.986	0.000
T40.8 Lysergide [LSD]	0.014	0.986	0.000
T40.7 Cannabis (derivatives)	0.014	0.986	0.000
T40.5 Cocaine	0.014	0.986	0.000
T40.3 Methadone	0.014	0.986	0.000
T40.1 Heroin	0.014	0.986	0.000
T40.0 Opium	0.014	0.986	0.000
C82.0 Small cleaved cell, follicular	0.013	0.987	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.013	0.987	0.000
C82.6 Cutaneous follicle centre lymphoma	0.013	0.987	0.000
C82.5 Diffuse follicle centre lymphoma	0.013	0.987	0.000
C82.4 Follicular lymphoma grade IIIb	0.013	0.987	0.000
T40.2 Other opioids	0.013	0.987	0.000
T49.9 Topical agent, unspecified	0.012	0.988	0.000
T49.8 Other topical agents	0.012	0.988	0.000
T49.7 Dental drugs, topically applied	0.012	0.988	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.012	0.988	0.000
T49.5 Ophthalmological drugs and preparations	0.012	0.988	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.012	0.988	0.000
T49.3 Emollients, demulcents and protectants	0.012	0.988	0.000
T49.2 Local astringents and local detergents	0.012	0.988	0.000
T49.1 Antipruritics	0.012	0.988	0.000
T40.6 Other and unspecified narcotics	0.012	0.988	0.000
T50.4 Drugs affecting uric acid metabolism	0.012	0.988	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.012	0.988	0.000
T50.8 Diagnostic agents	0.012	0.988	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.012	0.988	0.000
T41.5 Therapeutic gases	0.012	0.988	0.000
T41.4 Anaesthetic, unspecified	0.012	0.988	0.000
T41.3 Local anaesthetics	0.012	0.988	0.000
T41.2 Other and unspecified general anaesthetics	0.012	0.988	0.000
T41.1 Intravenous anaesthetics	0.012	0.988	0.000
T41.0 Inhaled anaesthetics	0.012	0.988	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.012	0.988	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.012	0.988	0.000
T48.5 Anti-common-cold drugs	0.012	0.988	0.000
T48.4 Expectorants	0.012	0.988	0.000
T48.3 Antitussives	0.012	0.988	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.012	0.988	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.012	0.988	0.000
T48.0 Oxytocic drugs	0.012	0.988	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.011	0.988	0.000
T37.5 Antiviral drugs	0.011	0.988	0.000
T37.4 Anthelminthics	0.011	0.988	0.000
T37.3 Other antiprotozoal drugs	0.011	0.988	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.011	0.988	0.000
T37.1 Antimycobacterial drugs	0.011	0.988	0.000
T37.0 Sulphonamides	0.011	0.988	0.000
N13.3 Other and unspecified hydronephrosis	0.012	0.988	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.011	0.989	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.011	0.989	0.000
T47.7 Emetics	0.011	0.989	0.000
T47.6 Antidiarrhoeal drugs	0.011	0.989	0.000
T47.5 Digestants	0.011	0.989	0.000
T47.4 Other laxatives	0.011	0.989	0.000
T47.3 Saline and osmotic laxatives	0.011	0.989	0.000
T47.2 Stimulant laxatives	0.011	0.989	0.000
T47.0 Histamine H(2)-receptor antagonists	0.011	0.989	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.011	0.989	0.000
T50.7 Analeptics and opioid receptor antagonists	0.011	0.989	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.011	0.989	0.000
T50.5 Appetite depressants	0.011	0.989	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.011	0.989	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.011	0.989	0.000
T50.1 Loop [high-ceiling] diuretics	0.011	0.989	0.000
T50.0 Mineralocorticoids and their antagonists	0.011	0.989	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.011	0.989	0.000
T36.9 Systemic antibiotic, unspecified	0.011	0.989	0.000
T36.8 Other systemic antibiotics	0.011	0.989	0.000
T36.7 Antifungal antibiotics, systemically used	0.011	0.989	0.000
T36.6 Rifamycins	0.011	0.989	0.000
T36.5 Aminoglycosides	0.011	0.989	0.000
T36.4 Tetracyclines	0.011	0.989	0.000
T36.3 Macrolides	0.011	0.989	0.000
T36.2 Chloramphenicol group	0.011	0.989	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.011	0.989	0.000
T42.1 Iminostilbenes	0.011	0.989	0.000
R25.2 Cramp and spasm	0.000	0.989	0.011
T47.1 Other antacids and anti-gastric-secretion drugs	0.011	0.989	0.000
Z34 Supervision of normal pregnancy	0.011	0.989	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.011	0.989	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.011	0.989	0.000
T42.3 Barbiturates	0.011	0.989	0.000
T42.2 Succinimides and oxazolidinediones	0.011	0.989	0.000
T36.0 Penicillins	0.010	0.990	0.000
T42.4 Benzodiazepines	0.010	0.990	0.000
M75.1 Rotator cuff syndrome	0.010	0.990	0.000
T42.0 Hydantoin derivatives	0.010	0.990	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.010	0.990	0.000
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.009	0.991	0.000
C50.8 Overlapping lesion of breast	0.009	0.991	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.009	0.991	0.000
T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand	0.009	0.991	0.000
T20-T25 Burns and corrosions of external body surface, specified by site	0.009	0.991	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.009	0.991	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.009	0.991	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.009	0.991	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.009	0.991	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.009	0.991	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.009	0.991	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.009	0.991	0.000
T44.0 Anticholinesterase agents	0.009	0.991	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.008	0.991	0.000
T45.2 Vitamins, not elsewhere classified	0.008	0.991	0.000
T22.3 Burn of third degree of shoulder and upper limb, except wrist and hand	0.008	0.992	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.008	0.992	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.008	0.992	0.000
T45.8 Other primarily systemic and haematological agents	0.008	0.992	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.008	0.992	0.000
T45.6 Fibrinolysis-affecting drugs	0.008	0.992	0.000
T45.4 Iron and its compounds	0.008	0.992	0.000
T45.3 Enzymes, not elsewhere classified	0.008	0.992	0.000
T21 Burn and corrosion of trunk	0.008	0.992	0.000
A41.1 Septicaemia due to other specified staphylococcus	0.008	0.992	0.000
R25 Abnormal involuntary movements	0.000	0.992	0.008
T23 Burn and corrosion of wrist and hand	0.008	0.992	0.000
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.008	0.992	0.000
Z34.0 Supervision of normal first pregnancy	0.008	0.992	0.000
T23.2 Burn of second degree of wrist and hand	0.008	0.992	0.000
R25.3 Fasciculation	0.000	0.992	0.008
T45.5 Anticoagulants	0.007	0.992	0.000
T22.1 Burn of first degree of shoulder and upper limb, except wrist and hand	0.007	0.993	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.007	0.993	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.007	0.993	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.007	0.993	0.000
T25 Burn and corrosion of ankle and foot	0.007	0.993	0.000
T22.7 Corrosion of third degree of shoulder and upper limb, except wrist and hand	0.007	0.993	0.000
T22.6 Corrosion of second degree of shoulder and upper limb, except wrist and hand	0.007	0.993	0.000
T22.5 Corrosion of first degree of shoulder and upper limb, except wrist and hand	0.007	0.993	0.000
T22.4 Corrosion of unspecified degree of shoulder and upper limb, except wrist and hand	0.007	0.993	0.000
T22.0 Burn of unspecified degree of shoulder and upper limb, except wrist and hand	0.007	0.993	0.000
T20 Burn and corrosion of head and neck	0.007	0.993	0.000
T21.2 Burn of second degree of trunk	0.007	0.993	0.000
Z34.9 Supervision of normal pregnancy, unspecified	0.007	0.993	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.007	0.993	0.000
C83.3 Large cell (diffuse)	0.007	0.993	0.000
F10.0 Acute intoxication	0.007	0.993	0.000
T21.0 Burn of unspecified degree of trunk	0.007	0.993	0.000
T21.1 Burn of first degree of trunk	0.007	0.993	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.006	0.993	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.006	0.993	0.000
T46.7 Peripheral vasodilators	0.006	0.993	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.006	0.993	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.006	0.993	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.006	0.993	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.006	0.993	0.000
T24.3 Burn of third degree of hip and lower limb, except ankle and foot	0.006	0.993	0.000
T45.0 Antiallergic and antiemetic drugs	0.006	0.993	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.007	0.993	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.006	0.994	0.000
T24.2 Burn of second degree of hip and lower limb, except ankle and foot	0.006	0.994	0.000
F60.3 Emotionally unstable personality disorder	0.006	0.994	0.000
T21.3 Burn of third degree of trunk	0.006	0.994	0.000
T21.7 Corrosion of third degree of trunk	0.006	0.994	0.000
T21.6 Corrosion of second degree of trunk	0.006	0.994	0.000
T21.5 Corrosion of first degree of trunk	0.006	0.994	0.000
T21.4 Corrosion of unspecified degree of trunk	0.006	0.994	0.000
R25.1 Tremor, unspecified	0.000	0.994	0.006
F60 Specific personality disorders	0.006	0.994	0.000
T20.2 Burn of second degree of head and neck	0.006	0.994	0.000
R25.0 Abnormal head movements	0.000	0.994	0.006
T23.7 Corrosion of third degree of wrist and hand	0.006	0.994	0.000
T23.6 Corrosion of second degree of wrist and hand	0.006	0.994	0.000
T23.5 Corrosion of first degree of wrist and hand	0.006	0.994	0.000
T23.4 Corrosion of unspecified degree of wrist and hand	0.006	0.994	0.000
T23.1 Burn of first degree of wrist and hand	0.006	0.994	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.994	0.000
T25.2 Burn of second degree of ankle and foot	0.006	0.994	0.000
D61.9 Aplastic anaemia, unspecified	0.006	0.994	0.000
T24.7 Corrosion of third degree of hip and lower limb, except ankle and foot	0.006	0.994	0.000
T24.6 Corrosion of second degree of hip and lower limb, except ankle and foot	0.006	0.994	0.000
T24.5 Corrosion of first degree of hip and lower limb, except ankle and foot	0.006	0.994	0.000
T24.4 Corrosion of unspecified degree of hip and lower limb, except ankle and foot	0.006	0.994	0.000
T24.1 Burn of first degree of hip and lower limb, except ankle and foot	0.006	0.994	0.000
C91 Lymphoid leukaemia	0.006	0.994	0.000
R25.8 Other and unspecified abnormal involuntary movements	0.000	0.994	0.006
F69 Unspecified disorder of adult personality and behaviour	0.006	0.994	0.000
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot	0.005	0.994	0.000
T23.0 Burn of unspecified degree of wrist and hand	0.005	0.994	0.000
F60-F69 Disorders of adult personality and behaviour	0.006	0.994	0.000
T20.1 Burn of first degree of head and neck	0.005	0.994	0.000
T25.7 Corrosion of third degree of ankle and foot	0.005	0.995	0.000
T25.6 Corrosion of second degree of ankle and foot	0.005	0.995	0.000
T25.5 Corrosion of first degree of ankle and foot	0.005	0.995	0.000
T25.4 Corrosion of unspecified degree of ankle and foot	0.005	0.995	0.000
T25.3 Burn of third degree of ankle and foot	0.005	0.995	0.000
T25.1 Burn of first degree of ankle and foot	0.005	0.995	0.000
T25.0 Burn of unspecified degree of ankle and foot	0.005	0.995	0.000
C91.4 Hairy-cell leukaemia	0.005	0.995	0.000
T20.7 Corrosion of third degree of head and neck	0.005	0.995	0.000
T20.6 Corrosion of second degree of head and neck	0.005	0.995	0.000
T20.5 Corrosion of first degree of head and neck	0.005	0.995	0.000
T20.4 Corrosion of unspecified degree of head and neck	0.005	0.995	0.000
T20.3 Burn of third degree of head and neck	0.005	0.995	0.000
C88 Malignant immunoproliferative diseases	0.005	0.995	0.000
C83.1 Small cleaved cell (diffuse)	0.005	0.995	0.000
F60.9 Personality disorder, unspecified	0.005	0.995	0.000
F06.7 Mild cognitive disorder	0.005	0.995	0.000
T23.3 Burn of third degree of wrist and hand	0.005	0.995	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.005	0.995	0.000
T46.1 Calcium-channel blockers	0.005	0.995	0.001
C81 Hodgkin's disease	0.005	0.995	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.005	0.995	0.000
C94 Other leukaemias of specified cell type	0.005	0.995	0.000
C86 Other specified types of T/NK-cell lymphoma	0.005	0.995	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.005	0.995	0.000
C91.0 Acute lymphoblastic leukaemia	0.005	0.995	0.000
C93 Monocytic leukaemia	0.005	0.995	0.000
C83.6 Undifferentiated (diffuse)	0.005	0.995	0.000
C83.5 Lymphoblastic (diffuse)	0.005	0.995	0.000
C83.4 Immunoblastic (diffuse)	0.005	0.995	0.000
C83.2 Mixed small and large cell (diffuse)	0.005	0.995	0.000
T20.0 Burn of unspecified degree of head and neck	0.005	0.995	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.005	0.995	0.000
F60.7 Dependent personality disorder	0.005	0.995	0.000
M43.16 Spondylolisthesis (Lumbar region)	0.000	0.995	0.005
F10 Mental and behavioural disorders due to use of alcohol	0.005	0.995	0.000
C83.7 Burkitt's tumour	0.005	0.995	0.000
F61 Mixed and other personality disorders	0.005	0.995	0.000
F10.5 Psychotic disorder	0.005	0.995	0.000
C91.9 Lymphoid leukaemia, unspecified	0.005	0.995	0.000
C81.9 Hodgkin's disease, unspecified	0.005	0.995	0.000
F60.8 Other specific personality disorders	0.004	0.995	0.000
F60.4 Histrionic personality disorder	0.004	0.995	0.000
F60.2 Dissocial personality disorder	0.004	0.995	0.000
F60.1 Schizoid personality disorder	0.004	0.995	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.004	0.996	0.000
F60.0 Paranoid personality disorder	0.004	0.996	0.000
C91.5 Adult T-cell leukaemia	0.004	0.996	0.000
C95 Leukaemia of unspecified cell type	0.004	0.996	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.001
C91.8 Mature B-cell leukaemia Burkitt-type	0.004	0.996	0.000
C91.7 Other lymphoid leukaemia	0.004	0.996	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.004	0.996	0.000
C91.3 Prolymphocytic leukaemia	0.004	0.996	0.000
C91.2 Subacute lymphocytic leukaemia	0.004	0.996	0.000
F68 Other disorders of adult personality and behaviour	0.004	0.996	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.004	0.996	0.000
F65 Disorders of sexual preference	0.004	0.996	0.000
F63 Habit and impulse disorders	0.004	0.996	0.000
F64 Gender identity disorders	0.004	0.996	0.000
F60.6 Anxious [avoidant] personality disorder	0.004	0.996	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.004	0.996	0.000
F10.4 Withdrawal state with delirium	0.004	0.996	0.000
F62.9 Enduring personality change, unspecified	0.004	0.996	0.000
F60.5 Anankastic personality disorder	0.004	0.996	0.000
G55.1 Nerve root and plexus compressions in intervertebral disk disorders	0.004	0.996	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.004	0.996	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.004	0.996	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.004	0.996	0.000
C88.7 Other malignant immunoproliferative diseases	0.004	0.996	0.000
C88.3 Immunoproliferative small intestinal disease	0.004	0.996	0.000
C88.2 Gamma heavy chain disease	0.004	0.996	0.000
C88.1 Alpha heavy chain disease	0.004	0.996	0.000
M48.06 Spinal stenosis (Lumbar region)	0.004	0.996	0.000
F10.7 Residual and late-onset psychotic disorder	0.004	0.996	0.000
C81.7 Other Hodgkin's disease	0.004	0.996	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.004	0.996	0.000
C81.3 Lymphocytic depletion	0.004	0.996	0.000
N10-N16 Renal tubulo-interstitial diseases	0.004	0.996	0.000
S20 Superficial injury of thorax	0.004	0.996	0.000
S20.8 Superficial injuries of other and unspecified parts of thorax	0.004	0.996	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.004	0.996	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.004	0.996	0.000
C86.4 Blastic NK-cell lymphoma	0.004	0.996	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.004	0.996	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.004	0.996	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.004	0.996	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.004	0.996	0.000
C94.7 Other specified leukaemias	0.004	0.996	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.004	0.996	0.000
C94.5 Acute myelofibrosis	0.004	0.996	0.000
C94.4 Acute panmyelosis	0.004	0.996	0.000
C94.3 Mast cell leukaemia	0.004	0.996	0.000
C94.2 Acute megakaryoblastic leukaemia	0.004	0.996	0.000
C94.1 Chronic erythraemia	0.004	0.996	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.004	0.996	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.004	0.996	0.000
C96.8 Histiocytic sarcoma	0.004	0.996	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.004	0.996	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.004	0.996	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.004	0.996	0.000
C96.3 True histiocytic lymphoma	0.004	0.996	0.000
C96.2 Malignant mast cell tumour	0.004	0.996	0.000
C96.1 Malignant histiocytosis	0.004	0.996	0.000
C96.0 Letterer-Siwe disease	0.004	0.996	0.000
F10.6 Amnesic syndrome	0.004	0.996	0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.004	0.996	0.000
C90.3 Solitary plasmacytoma	0.004	0.996	0.000
C81.1 Nodular sclerosis	0.004	0.996	0.000
C93.9 Monocytic leukaemia, unspecified	0.003	0.996	0.000
C93.7 Other monocytic leukaemia	0.003	0.996	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.003	0.996	0.000
C93.2 Subacute monocytic leukaemia	0.003	0.996	0.000
C93.0 Acute monocytic leukaemia	0.003	0.996	0.000
B80 Enterobiasis	0.004	0.996	0.000
C81.2 Mixed cellularity	0.004	0.996	0.000
F62.8 Other enduring personality changes	0.003	0.996	0.000
F62.1 Enduring personality change after psychiatric illness	0.003	0.996	0.000
F62.0 Enduring personality change after catastrophic experience	0.003	0.996	0.000
S20.3 Other superficial injuries of front wall of thorax	0.004	0.996	0.000
F10.8 Other mental and behavioural disorders	0.004	0.996	0.000
R73.0 Abnormal glucose tolerance test	0.004	0.996	0.000
F10.3 Withdrawal state	0.004	0.996	0.000
N87.0 Mild cervical dysplasia	0.004	0.996	0.000
C93.1 Chronic monocytic leukaemia	0.003	0.996	0.000
C83.0 Small cell (diffuse)	0.003	0.996	0.000
C77.5 Intrapelvic lymph nodes	0.004	0.996	0.000
C90.1 Plasma cell leukaemia	0.003	0.997	0.000
S20.2 Contusion of thorax	0.003	0.997	0.000
C81.0 Lymphocytic predominance	0.003	0.997	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
C95.7 Other leukaemia of unspecified cell type	0.003	0.997	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.003	0.997	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.003	0.997	0.000
C95.0 Acute leukaemia of unspecified cell type	0.003	0.997	0.000
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.003	0.997	0.000
F63.9 Habit and impulse disorder, unspecified	0.003	0.997	0.000
F63.8 Other habit and impulse disorders	0.003	0.997	0.000
F63.3 Trichotillomania	0.003	0.997	0.000
F63.2 Pathological stealing [kleptomania]	0.003	0.997	0.000
F63.1 Pathological fire-setting [pyromania]	0.003	0.997	0.000
F63.0 Pathological gambling	0.003	0.997	0.000
F65.9 Disorder of sexual preference, unspecified	0.003	0.997	0.000
F65.8 Other disorders of sexual preference	0.003	0.997	0.000
F65.6 Multiple disorders of sexual preference	0.003	0.997	0.000
F65.5 Sadomasochism	0.003	0.997	0.000
F65.4 Paedophilia	0.003	0.997	0.000
F65.3 Voyeurism	0.003	0.997	0.000
F65.2 Exhibitionism	0.003	0.997	0.000
F65.1 Fetishistic transvestism	0.003	0.997	0.000
F65.0 Fetishism	0.003	0.997	0.000
F66.9 Psychosexual development disorder, unspecified	0.003	0.997	0.000
F66.8 Other psychosexual development disorders	0.003	0.997	0.000
F66.2 Sexual relationship disorder	0.003	0.997	0.000
F66.1 Egodystonic sexual orientation	0.003	0.997	0.000
F66.0 Sexual maturation disorder	0.003	0.997	0.000
F68.8 Other specified disorders of adult personality and behaviour	0.003	0.997	0.000
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]	0.003	0.997	0.000
F68.0 Elaboration of physical symptoms for psychological reasons	0.003	0.997	0.000
F64.9 Gender identity disorder, unspecified	0.003	0.997	0.000
F64.8 Other gender identity disorders	0.003	0.997	0.000
F64.2 Gender identity disorder of childhood	0.003	0.997	0.000
F64.1 Dual-role transvestism	0.003	0.997	0.000
S20.1 Other and unspecified superficial injuries of breast	0.003	0.997	0.000
F64.0 Transsexualism	0.003	0.997	0.000
S20.0 Contusion of breast	0.003	0.997	0.000
N11 Chronic tubulo-interstitial nephritis	0.003	0.997	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.003	0.997	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.003	0.997	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.003	0.997	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.003	0.997	0.000
C84.3 Lymphoepithelioid lymphoma	0.003	0.997	0.000
C84.2 T-zone lymphoma	0.003	0.997	0.000
C84.1 Sezary's diease	0.003	0.997	0.000
C84.0 Mycosis fungoides	0.003	0.997	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.003	0.997	0.000
C85.0 Lymphosarcoma	0.003	0.997	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.003	0.997	0.000
C84.4 Peripheral T-cell lymphoma	0.003	0.997	0.000
R73.9 Hyperglycaemia, unspecified	0.003	0.997	0.000
F10.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.003	0.997	0.000
N15 Other renal tubulo-interstitial diseases	0.003	0.997	0.000
C90.2 Plasmacytoma, extramedullary	0.003	0.997	0.000
C77.1 Intrathoracic lymph nodes	0.003	0.997	0.000
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.003	0.997	0.000
S20.7 Multiple superficial injuries of thorax	0.003	0.997	0.000
S20.4 Other superficial injuries of back wall of thorax	0.003	0.997	0.000
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.003	0.997	0.000
F06.6 Organic emotionally labile [asthenic] disorder	0.003	0.997	0.000
F06.5 Organic dissociative disorder	0.003	0.997	0.000
F06.4 Organic anxiety disorder	0.003	0.997	0.000
F06.3 Organic mood [affective] disorders	0.003	0.997	0.000
F06.2 Organic delusional [schizophrenia-like] disorder	0.003	0.997	0.000
F06.1 Organic catatonic disorder	0.003	0.997	0.000
F06.0 Organic hallucinosis	0.003	0.997	0.000
M43.1 Spondylolisthesis	0.000	0.997	0.003
N15.1 Renal and perinephric abscess	0.003	0.997	0.000
C85.1 B-cell lymphoma, unspecified	0.003	0.997	0.000
F11.2 Dependence syndrome	0.003	0.997	0.000
C90.0 Multiple myeloma	0.003	0.997	0.000
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.003	0.997	0.000
M43.17 Spondylolisthesis (Lumbosacral region)	0.000	0.997	0.003
F11 Mental and behavioural disorders due to use of opioids	0.003	0.997	0.000
C77.4 Inguinal and lower limb lymph nodes	0.003	0.997	0.000
C95.9 Leukaemia, unspecified	0.002	0.997	0.000
D61 Other aplastic anaemias	0.003	0.997	0.000
R73 Elevated blood glucose level	0.003	0.997	0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.003	0.997	0.000
C92 Myeloid leukaemia	0.003	0.997	0.000
N11.1 Chronic obstructive pyelonephritis	0.003	0.997	0.000
N81.5 Vaginal enterocele	0.000	0.997	0.003
C80.9 Malignant neoplasm, unspecified	0.003	0.997	0.000
K20 Oesophagitis	0.000	0.997	0.003
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.003	0.997	0.000
N11.8 Other chronic tubulo-interstitial nephritis	0.002	0.997	0.000
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.002	0.997	0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.002	0.997	0.000
M43.12 Spondylolisthesis (Cervical region)	0.000	0.997	0.002
O14.9 Preeclampsia, unspecified	0.003	0.997	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.002	0.997	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.002	0.997	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.003	0.997	0.000
C92.7 Other myeloid leukaemia	0.002	0.997	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.002	0.997	0.000
N15.8 Other specified renal tubulo-interstitial diseases	0.002	0.997	0.000
N15.0 Balkan nephropathy	0.002	0.997	0.000
S01.5 Open wound of lip and oral cavity	0.003	0.997	0.000
T13.1 Open wound of lower limb, level unspecified	0.002	0.997	0.000
F18 Mental and behavioural disorders due to use of volatile solvents	0.002	0.997	0.000
F16 Mental and behavioural disorders due to use of hallucinogens	0.002	0.997	0.000
F14 Mental and behavioural disorders due to use of cocaine	0.002	0.997	0.000
F51.0 Nonorganic insomnia	0.002	0.997	0.000
F51 Nonorganic sleep disorders	0.002	0.997	0.000
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere	0.002	0.998	0.000
N16.5 Renal tubulo-interstitial disorders in transplant rejection	0.002	0.998	0.000
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders	0.002	0.998	0.000
N16.3 Renal tubulo-interstitial disorders in metabolic diseases	0.002	0.998	0.000
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism	0.002	0.998	0.000
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases	0.002	0.998	0.000
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
F50 Eating disorders	0.002	0.998	0.000
C15.9 Oesophagus, unspecified	0.000	0.998	0.002
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M43.15 Spondylolisthesis (Thoracolumbar region)	0.000	0.998	0.002
M43.14 Spondylolisthesis (Thoracic region)	0.000	0.998	0.002
M43.13 Spondylolisthesis (Cervicothoracic region)	0.000	0.998	0.002
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M50.1 Cervical disk disorder with radiculopathy	0.002	0.998	0.000
W18.5 Trade and service area	0.002	0.998	0.000
T09 Other injuries of spine and trunk, level unspecified	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.002	0.998	0.000
T51.0 Ethanol	0.002	0.998	0.000
F50.2 Bulimia nervosa	0.002	0.998	0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.002	0.998	0.000
N14.4 Toxic nephropathy, not elsewhere classified	0.002	0.998	0.000
N14.3 Nephropathy induced by heavy metals	0.002	0.998	0.000
N14.2 Nephropathy induced by unspecified drug, medicament or biological substance	0.002	0.998	0.000
N14.0 Analgesic nephropathy	0.002	0.998	0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.002	0.998	0.000
Chapter V Mental and behavioural disorders	0.002	0.998	0.000
F11.9 Unspecified mental and behavioural disorder	0.002	0.998	0.000
F11.8 Other mental and behavioural disorders	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations